drugset / Trial / NCT00755404
Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
RandomizedParallel-groupOpen-labelTreatment
Summary
The current study is initiated in order to assess the impact of a PD solution containing L-carnitine on insulin sensitivity evaluated by measuring insulin requirement.
Timeline
- Start
- 2007-06
- Primary completion
- 2013-10
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 0.1 % | Other |
| Comparator | Glucose | Unknown | 1.5 % | Other |
| Comparator | Glucose | Unknown | 2.5 % | Other |
| Comparator | Icodextrin | Other / unclassified | 7.5 % | Other |